CANN
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Capitalization
4.25M
CNTMF
Price
$0.07
Change
-$0.01 (-12.50%)
Updated
Aug 15 closing price
Capitalization
40.76M
Interact to see
Advertisement

CANN vs CNTMF

Header iconCANN vs CNTMF Comparison
Open Charts CANN vs CNTMFBanner chart's image
TREES
Price$0.04
Change-$0.00 (-0.00%)
Volume$188.74K
Capitalization4.25M
FLUENT
Price$0.07
Change-$0.01 (-12.50%)
Volume$893.74K
Capitalization40.76M
CANN vs CNTMF Comparison Chart in %
Loading...
CANN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNTMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CANN vs. CNTMF commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CANN is a Hold and CNTMF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (CANN: $0.04 vs. CNTMF: $0.07)
Brand notoriety: CANN and CNTMF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CANN: 114% vs. CNTMF: 394%
Market capitalization -- CANN: $4.25M vs. CNTMF: $40.76M
CANN [@Pharmaceuticals: Generic] is valued at $4.25M. CNTMF’s [@Pharmaceuticals: Generic] market capitalization is $40.76M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CANN’s FA Score shows that 0 FA rating(s) are green whileCNTMF’s FA Score has 0 green FA rating(s).

  • CANN’s FA Score: 0 green, 5 red.
  • CNTMF’s FA Score: 0 green, 5 red.
According to our system of comparison, CNTMF is a better buy in the long-term than CANN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CANN’s TA Score shows that 7 TA indicator(s) are bullish while CNTMF’s TA Score has 5 bullish TA indicator(s).

  • CANN’s TA Score: 7 bullish, 3 bearish.
  • CNTMF’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CANN is a better buy in the short-term than CNTMF.

Price Growth

CANN (@Pharmaceuticals: Generic) experienced а +160.27% price change this week, while CNTMF (@Pharmaceuticals: Generic) price change was -8.94% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTMF($40.8M) has a higher market cap than CANN($4.25M). CANN YTD gains are higher at: 116.889 vs. CNTMF (-7.904). CANN has higher annual earnings (EBITDA): 619K vs. CNTMF (-423K). CNTMF has more cash in the bank: 26.2M vs. CANN (245K). CANN has less debt than CNTMF: CANN (17.4M) vs CNTMF (133M). CNTMF has higher revenues than CANN: CNTMF (105M) vs CANN (14.5M).
CANNCNTMFCANN / CNTMF
Capitalization4.25M40.8M10%
EBITDA619K-423K-146%
Gain YTD116.889-7.904-1,479%
P/E RatioN/AN/A-
Revenue14.5M105M14%
Total Cash245K26.2M1%
Total Debt17.4M133M13%
FUNDAMENTALS RATINGS
CANN vs CNTMF: Fundamental Ratings
CANN
CNTMF
OUTLOOK RATING
1..100
7359
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3744
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CNTMF's Valuation (64) in the null industry is in the same range as CANN (69). This means that CNTMF’s stock grew similarly to CANN’s over the last 12 months.

CNTMF's Profit vs Risk Rating (100) in the null industry is in the same range as CANN (100). This means that CNTMF’s stock grew similarly to CANN’s over the last 12 months.

CNTMF's SMR Rating (98) in the null industry is in the same range as CANN (100). This means that CNTMF’s stock grew similarly to CANN’s over the last 12 months.

CANN's Price Growth Rating (37) in the null industry is in the same range as CNTMF (44). This means that CANN’s stock grew similarly to CNTMF’s over the last 12 months.

CNTMF's P/E Growth Rating (97) in the null industry is in the same range as CANN (100). This means that CNTMF’s stock grew similarly to CANN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CANNCNTMF
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CANN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNTMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMPRF2.02N/A
N/A
Gentera Sab De CV
OMVJF54.34N/A
N/A
OMV AG
MRGO8.50N/A
N/A
Margo Caribe, Inc.
TDCSF9.00N/A
N/A
Tdc Software Engineering Inc.
MAGMF0.09N/A
N/A
MAGMA SILVER CORP.

CANN and

Correlation & Price change

A.I.dvisor tells us that CANN and MEDIF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CANN and MEDIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANN
1D Price
Change %
CANN100%
-9.82%
MEDIF - CANN
22%
Poorly correlated
-7.67%
SFOSF - CANN
21%
Poorly correlated
N/A
CGC - CANN
20%
Poorly correlated
-12.75%
CNTMF - CANN
14%
Poorly correlated
-12.53%
CAIHF - CANN
12%
Poorly correlated
N/A
More

CNTMF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTMF has been loosely correlated with TCNNF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTMF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTMF
1D Price
Change %
CNTMF100%
-12.53%
TCNNF - CNTMF
49%
Loosely correlated
-7.35%
VRNOF - CNTMF
41%
Loosely correlated
-19.33%
GTBIF - CNTMF
39%
Loosely correlated
-12.40%
CURLF - CNTMF
38%
Loosely correlated
-9.48%
CRLBF - CNTMF
36%
Loosely correlated
-1.25%
More